OPTIBIOTIX HEALTH PLC Logo

OPTIBIOTIX HEALTH PLC

Develops microbiome-modulating ingredients to manage chronic lifestyle diseases.

OPTI | IL

Overview

Corporate Details

ISIN(s):
GB00BP0RTP38
LEI:
213800UKYQFT941QHS14
Country:
United Kingdom
Address:
Innovation Centre Innovation Way, YO10 5DG York

Description

OptiBiotix Health PLC is a life sciences company specializing in the research and development of technologies that modulate the human microbiome. The company identifies and develops microbial strains, compounds, and formulations for use as food ingredients, dietary supplements, and active compounds. Its primary focus is on the prevention and management of chronic lifestyle diseases, including obesity, cardiovascular health issues such as high cholesterol, and diabetes. OptiBiotix's approach is founded on strong scientific evidence, with its product pipeline supported by clinical human studies. The company provides these clinically proven ingredients and white-label solutions to partners in the food, health, and wellness sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2023-06-28 08:00
Final Results
English HTML 667.7 KB
2023-05-04 08:00
Investor update
English HTML 13.6 KB
2023-03-21 08:00
Change of Broker
English HTML 14.8 KB
2023-03-15 08:00
Slimbiome study results
English HTML 19.4 KB
2023-02-21 08:00
Directorate Change
English HTML 18.8 KB
2022-12-05 08:00
Issue of Equity – Subscription
English HTML 20.6 KB
2022-11-10 12:30
Investor update
English HTML 13.8 KB
2022-11-01 08:00
Launch of GoFigure products on Tmall China
English HTML 13.8 KB
2022-10-24 08:00
Approval of GoFigure products
English HTML 15.6 KB
2022-10-17 08:00
New health claims for SlimBiome in Australia
English HTML 19.4 KB
2022-09-28 08:00
Half-year Report
English HTML 266.5 KB
2022-09-26 08:00
Launch of novel prebiotic in Europe and Africa
English HTML 18.1 KB
2022-09-20 08:00
Launch of GoFigure range with Apollo Hospitals
English HTML 17.3 KB
2022-09-14 08:00
New commercialisation partner in Asia Pacific
English HTML 17.0 KB
2022-08-24 17:41
Second Price Monitoring Extn
English HTML 2.8 KB

Automate Your Workflow. Get a real-time feed of all OPTIBIOTIX HEALTH PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OPTIBIOTIX HEALTH PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OPTIBIOTIX HEALTH PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.